Iovance Biotherapeutics, Inc. (0JDK.L) LSE

2.87

+0.11(+3.99%)

Updated at December 24 06:56PM

Currency In USD

Valuation

Market Cap2.08B
Enterprise Value2.02B
P/E Ratio-2.46
PEG Ratio-3.05
Price/Sales Ratio3.94
Price/Book Ratio1.37
Enterprise/Revenue3.61
Enterprise/EBITDA-2.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.61
Operating Margin-1.7

Management Effectiveness

Return On Assets-0.43
Return On Equity-0.53

Income Statement

Revenue164.07M
Revenue/Share0.72
Gross Profit17.67M
EBITDA-331.4M
Net Income-372.18M
Diluted EPS-1.28

Balance Sheet

Total Cash300.8M
Total Cash/Share0.9
Total Debt52.49M
Total Debt/Equity0.08
Current Ratio3.27
Book Value Per Share2.09

Price History

52-Week Change-60.63
52-Week High18.31
52-Week Low2.78
Moving Average 50 Days11.04
Moving Average 200 Days7.44

Statistics

Average Volume53,275
Shares Outstanding331.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A